To the Editor In the February 2020 issue of JAMA Surgery, Pusateri et al1 reported that prehospital plasma transfusion is associated with survival benefit when transport times are longer than 20 minutes and, more generally, that benefit-risk ratio is favorable for use of prehospital plasma. First, the authors must be congratulated for this impressive secondary post hoc analysis merging 2 randomized clinical trials with contrary results, COMBAT and PAMPer.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Jouffroy R, Vivien B. Prehospital Plasma Transfusion and Survival in Trauma Patients With Hemorrhagic Shock. JAMA Surg. Published online May 20, 2020. doi:10.1001/jamasurg.2020.1131
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: